FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913163651> ?p ?o ?g. }

• W2913163651 endingPage "143" @default.
• W2913163651 startingPage "133" @default.
• W2913163651 abstract "One out of six adults has symptoms of overactive bladder (OAB). Antimuscarinic medication is the main pharmacological group used in the treatment of OAB. In preclinical studies, antimuscarinic compounds have been found to inhibit cell proliferation in lung cancer and colon cancer.The aim of this study was to investigate the association between exposure to anti-muscarinic medication and the risk of lung cancer and colon cancer.Individuals in Sweden who first filled a prescription for an antimuscarinic medication used to treat OAB (ie, oxybutynin, solifenacin, darifenacin, fesoterodine, or tolterodine) between July 1, 2006, and December 31, 2012, were identified and classified as exposed. Each exposed individual was individually matched with up to ten unexposed individuals from the Swedish general population, based on year of birth, sex, and county of residence. Cox proportional hazard models with follow-up time as the underlying time scale were used to estimate HRs with 95% CIs.In total, 164,000 exposed and 1,446,472 unexposed individuals were included in this study. The estimated HRs for lung cancer, in follow-up time intervals of <1 year, 1-4 years, and ≥4 years, were as follows: 0.86 (95% CI: 0.75-0.98), 0.63 (95% CI: 0.56-0.70), and 0.43 (0.34-0.55), respectively. The corresponding estimates for colon cancer were as follows: 0.91 (95% CI: 0.80-1.03), 0.81 (95% CI: 0.74-0.88), and 0.61 (95% CI: 0.51-0.73), respectively.There was an inverse association between exposure to antimuscarinic medications, used in the treatment of OAB, and a diagnosis of colon cancer or lung cancer, which is in line with the findings in preclinical studies." @default.
• W2913163651 created "2019-02-21" @default.
• W2913163651 creator A5007122786 @default.
• W2913163651 creator A5011479329 @default.
• W2913163651 creator A5022338649 @default.
• W2913163651 creator A5042991274 @default.
• W2913163651 creator A5068646928 @default.
• W2913163651 date "2019-01-01" @default.
• W2913163651 modified "2023-10-18" @default.
• W2913163651 title "<p>Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer</p>" @default.
• W2913163651 cites W1487366477 @default.
• W2913163651 cites W1569773153 @default.
• W2913163651 cites W1781497087 @default.
• W2913163651 cites W1798063743 @default.
• W2913163651 cites W1966293775 @default.
• W2913163651 cites W1967312126 @default.
• W2913163651 cites W1967347194 @default.
• W2913163651 cites W1974278114 @default.
• W2913163651 cites W1976436028 @default.
• W2913163651 cites W1980341722 @default.
• W2913163651 cites W1997013992 @default.
• W2913163651 cites W2000368095 @default.
• W2913163651 cites W2000445173 @default.
• W2913163651 cites W2003429956 @default.
• W2913163651 cites W2005563893 @default.
• W2913163651 cites W2011643740 @default.
• W2913163651 cites W2034039888 @default.
• W2913163651 cites W2049623777 @default.
• W2913163651 cites W2058823385 @default.
• W2913163651 cites W2064938489 @default.
• W2913163651 cites W2068572076 @default.
• W2913163651 cites W2071785245 @default.
• W2913163651 cites W2077791460 @default.
• W2913163651 cites W2084286451 @default.
• W2913163651 cites W2098709306 @default.
• W2913163651 cites W2134928141 @default.
• W2913163651 cites W2141761576 @default.
• W2913163651 cites W2153400203 @default.
• W2913163651 cites W2155381616 @default.
• W2913163651 cites W2157021912 @default.
• W2913163651 cites W2166018731 @default.
• W2913163651 cites W2168021466 @default.
• W2913163651 cites W2233885014 @default.
• W2913163651 cites W2294982910 @default.
• W2913163651 cites W2793910813 @default.
• W2913163651 cites W332394075 @default.
• W2913163651 cites W4243531139 @default.
• W2913163651 doi "https://doi.org/10.2147/clep.s186842" @default.
• W2913163651 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6350836" @default.
• W2913163651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30774448" @default.
• W2913163651 hasPublicationYear "2019" @default.
• W2913163651 type Work @default.
• W2913163651 sameAs 2913163651 @default.
• W2913163651 citedByCount "7" @default.
• W2913163651 countsByYear W29131636512020 @default.
• W2913163651 countsByYear W29131636512021 @default.
• W2913163651 countsByYear W29131636512022 @default.
• W2913163651 countsByYear W29131636512023 @default.
• W2913163651 crossrefType "journal-article" @default.
• W2913163651 hasAuthorship W2913163651A5007122786 @default.
• W2913163651 hasAuthorship W2913163651A5011479329 @default.
• W2913163651 hasAuthorship W2913163651A5022338649 @default.
• W2913163651 hasAuthorship W2913163651A5042991274 @default.
• W2913163651 hasAuthorship W2913163651A5068646928 @default.
• W2913163651 hasBestOaLocation W29131636511 @default.
• W2913163651 hasConcept C121608353 @default.
• W2913163651 hasConcept C126322002 @default.
• W2913163651 hasConcept C126894567 @default.
• W2913163651 hasConcept C142724271 @default.
• W2913163651 hasConcept C143998085 @default.
• W2913163651 hasConcept C204787440 @default.
• W2913163651 hasConcept C207103383 @default.
• W2913163651 hasConcept C2776256026 @default.
• W2913163651 hasConcept C2777844464 @default.
• W2913163651 hasConcept C2778527826 @default.
• W2913163651 hasConcept C2778941218 @default.
• W2913163651 hasConcept C2779502394 @default.
• W2913163651 hasConcept C2780352672 @default.
• W2913163651 hasConcept C2781020410 @default.
• W2913163651 hasConcept C2908647359 @default.
• W2913163651 hasConcept C29456083 @default.
• W2913163651 hasConcept C44249647 @default.
• W2913163651 hasConcept C526805850 @default.
• W2913163651 hasConcept C71924100 @default.
• W2913163651 hasConcept C90924648 @default.
• W2913163651 hasConcept C99454951 @default.
• W2913163651 hasConceptScore W2913163651C121608353 @default.
• W2913163651 hasConceptScore W2913163651C126322002 @default.
• W2913163651 hasConceptScore W2913163651C126894567 @default.
• W2913163651 hasConceptScore W2913163651C142724271 @default.
• W2913163651 hasConceptScore W2913163651C143998085 @default.
• W2913163651 hasConceptScore W2913163651C204787440 @default.
• W2913163651 hasConceptScore W2913163651C207103383 @default.
• W2913163651 hasConceptScore W2913163651C2776256026 @default.
• W2913163651 hasConceptScore W2913163651C2777844464 @default.
• W2913163651 hasConceptScore W2913163651C2778527826 @default.
• W2913163651 hasConceptScore W2913163651C2778941218 @default.
• W2913163651 hasConceptScore W2913163651C2779502394 @default.

• next